At a glance
- Originator NitroMed
- Developer Nivalis Therapeutics
- Class Amides; Anti-inflammatories; Antiasthmatics; Carboxylic acids; Pyrroles; Small molecules
- Mechanism of Action Alcohol dehydrogenase inhibitors; Glutathione-independent formaldehyde dehydrogenase inhibitors; Nitric oxide stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Acute asthma; Asthma; Chronic obstructive pulmonary disease; Inflammatory bowel diseases
- Discontinued Cystic fibrosis